She was given cefepime 2 gm IV, vancomycin 1 gram IV, and levaquin 750 mg IV.
Past Medical History: Atrial fibrillation on Coumadin Osteoporosis Mitral valve prolapse with 3+ MR.
Pertinent Results: [**2152-4-29**] 10:30PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.019 [**2152-4-29**] 10:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-TR [**2152-4-29**] 10:30PM URINE  RBC-1 WBC-13* BACTERIA-FEW YEAST-RARE EPI-0 [**2152-4-29**] 10:30PM URINE  HYALINE-1* [**2152-4-29**] 10:30PM URINE  MUCOUS-RARE [**2152-4-29**] 10:25PM   TYPE-ART O2-100 O2 FLOW-15 PO2-299* PCO2-62* PH-7.28* TOTAL CO2-30 BASE XS-1 AADO2-368 REQ O2-64 INTUBATED-NOT INTUBA COMMENTS-SIMPLE FAC [**2152-4-29**] 10:25PM   LACTATE-1.1 [**2152-4-29**] 09:59PM   LACTATE-2.4* K+-4.2 [**2152-4-29**] 09:45PM   GLUCOSE-116* UREA N-39* CREAT-0.9 SODIUM-141 POTASSIUM-4.8 CHLORIDE-103 TOTAL CO2-28 ANION GAP-15 [**2152-4-29**] 09:45PM   proBNP-[**Numeric Identifier 17406**]* [**2152-4-29**] 09:45PM   CALCIUM-8.8 PHOSPHATE-4.0 MAGNESIUM-2.3 [**2152-4-29**] 09:45PM   DIGOXIN-1.2 [**2152-4-29**] 09:45PM   WBC-14.3* RBC-4.22 HGB-12.9 HCT-40.7 MCV-96 MCH-30.6 MCHC-31.7 RDW-14.9 [**2152-4-29**] 09:45PM   NEUTS-88.8* LYMPHS-8.1* MONOS-2.3 EOS-0.3 BASOS-0.6 [**2152-4-29**] 09:45PM   PLT COUNT-790* [**2152-4-29**] 09:45PM   PT-40.1* PTT-31.5 INR(PT)-4.1* .
ST-depression in I, V4-V6.
She tolerated BiPAP and did not require intubation.
She was recently admitted to the ICU with pneumonia; The MICU staff treated her again with vancomycin, cefepime, levofloxacin for suspected aspiration pneumonia.
Her atrial fibrillation was rate controlled with increased doses of Diltiazem ( 90 MG Q 6 hours then 360 of Cardiazem CD; she could not swallow the latter and therefore she was discharged on the short acting).
Her Coumadin was held for supra therapeutic INR and the rate was controlled with digoxin and Diltiazem.
She was then treated with Coumadin and Heparin bridge as well as IV Lasix and her antibiotics were stopped.
She tolerated thin liquids and regular consistency solids without any overt or soft signs of aspiration.
She did not have symptoms consistant possible reflux and aspiration and she was be advanced to thin liquids and regular consistency solids.
She did not undergo TEE with cardioversion because of the severe esophageal narrowing.
He had to use an ultra-thin 4.5 mm scope, leave a wire, dilate up with [**Last Name (un) 17407**] dilators to 12 mm.
Discharge Medications: 1. digoxin 125 mcg Tablet [**Last Name (un) **]: One (1) Tablet PO DAILY (Daily).
2. lansoprazole 30 mg Tablet,Rapid Dissolve, DR [**Last Name (STitle) **]: One (1) Tablet,Rapid Dissolve, DR [**Last Name (STitle) **] DAILY (Daily).
Disp:*30 Tablet,Rapid Dissolve, DR(s)* Refills:*2* 3. warfarin 2 mg Tablet [**Last Name (STitle) **]: Two (2) Tablet PO Once Daily at 4 PM.
Disp:*60 Tablet(s)* Refills:*2* 4. furosemide 20 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO DAILY (Daily).
Outpatient Physical Therapy 3 time a week 6. diltiazem HCl 90 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO four times a day.
Disp:*120 Tablet(s)* Refills:*2*   Discharge Disposition: Home  Discharge Diagnosis: pulmonary edema atrial fibrillation acute diastolic heart failure prolapsed and regurgitant mitral valve cardioversion esophageal narrowings that was treated with Botox injections.
We also found esophageal narrowings that was treated with Botox injections.
